[2 MIN READ]
This article is part of a paid branded content series with Get Creative, a division of USA Today. The article originally appeared on USA Today here.
Providence Cancer Institute celebrates Advanced Practice Providers Week from September 25 to 29 and recognizes their important contributions more than 25 clinics and programs.
Providence Swedish is at the forefront of new technologies that decrease pain and shorten recovery time for prostate cancer patients.
Providence Cancer Institute of Oregon announces new division director and deputy director of Hematology and Medical Oncology.
While rates of lung cancer have dropped with successful campaigns to curb smoking, lung cancer remains a problem – including for non-smokers. Learn how.
For Gynecologic Cancer Awareness Month, Providence Cancer Institute highlights a clinical trial that evaluates the safety and effectiveness of a new oral treatment for grade 1 endometrial cancer.
New trial open at Earle A. Chiles Research Institute, a division of Providence Cancer Institute of Oregon, is enrolling patients with advanced or metastatic solid tumors or non-Hodgkin lymphoma.
What’s in your DNA matters. From your risk for developing certain diseases to what treatments might work best for you, it’s all written in your genes.
A global study co-authored by Providence researchers shows significant promise for the treatment of Chronic lymphocytic leukemia/Small Lymphocytic Lymphoma
World Lung Cancer Day is a time to support those living with lung cancer and work to prevent it in the future. See how Providence is recognizing this day.
A phase II trial tests FOLFOX or CAPOX versus FOLFIRINOX in patients with locally advanced rectal cancer, and a phase I trial evaluates TBio-4101 in patients with advanced solid tumors.
Final outcomes from a Providence Cancer Institute-sponsored phase Ib trial evaluating pembrolizumab with either weekly paclitaxel or flat-dose capecitabine in treating patients with metastatic TNBC.
Researchers from Earle A. Chiles Research Institute, a division of Providence Cancer Institute of Oregon, shared their investigations to advance cancer research and treatments at the premier event.
Providence's Pavilion for Women and Children is hosting a Women's Wellness Day Cancer Screening event on July 15th.
More than ever, cancer is a disease that people survive. From the day we meet you, your survivorship is the goal we have in mind as we develop and deliver your personalized treatment plan. Once your t
Celebrating and Supporting Cancer Survivors
Portland painter credits the support of Providence providers and creating art for helping her recover and heal from breast cancer and the loss of her mother.
Virtual talks at Providence highlight MRI-guided radiation therapy for treating breast cancer, pancreatic cancer treatments, and sexual health during and after ovarian cancer.
New investigator-initiated trial at Providence to evaluate a triple combination of medications for treating melanoma, and two new studies evaluating medication combinations to treat AML.
Providence researchers awarded an R21 grant from the National Institutes of Health which provides funding for projects with potential to significantly advance biomedical research.
